Cyrille M - Search Results

1

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate-to-Severe Ulcerative Colitis.

Sandborn WJ, Cyrille M, Hansen MB, Feagan BG, Loftus EV Jr, Rogler G, Vermeire S, Cruz ML, Yang J, Boedigheimer MJ, Abuqayyas L, Evangelista CM, Sullivan BA, Reinisch W. Sandborn WJ, et al. Among authors: cyrille m. Gastroenterology. 2019 Mar;156(4):946-957.e18. doi: 10.1053/j.gastro.2018.11.035. Epub 2018 Nov 23. Gastroenterology. 2019. PMID: 30472236 Free article. Clinical Trial.

2

Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial.

Koba S, Inoue I, Cyrille M, Lu C, Inomata H, Shimauchi J, Kajinami K. Koba S, et al. Among authors: cyrille m. J Atheroscler Thromb. 2020 May 1;27(5):471-484. doi: 10.5551/jat.50963. Epub 2019 Nov 21. J Atheroscler Thromb. 2020. PMID: 31748467 Free PMC article. Clinical Trial.

3

Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristics.

Boccara F, Kumar P, Caramelli B, Calmy A, López JAG, Bray S, Cyrille M, Rosenson RS. Boccara F, et al. Among authors: cyrille m. Am Heart J. 2020 Feb;220:203-212. doi: 10.1016/j.ahj.2019.11.004. Epub 2019 Nov 12. Am Heart J. 2020. PMID: 31841795 Free article. Clinical Trial.

4

Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK Study.

Boccara F, Kumar PN, Caramelli B, Calmy A, López JAG, Bray S, Cyrille M, Rosenson RS; BEIJERINCK Investigators. Boccara F, et al. Among authors: cyrille m. J Am Coll Cardiol. 2020 May 26;75(20):2570-2584. doi: 10.1016/j.jacc.2020.03.025. Epub 2020 Mar 28. J Am Coll Cardiol. 2020. PMID: 32234462 Free article. Clinical Trial.

5

One-Year Efficacy and Safety of Evolocumab in Japanese Patients　- A Pooled Analysis From the Open-Label Extension OSLER Studies.

Hirayama A, Yamashita S, Inomata H, Kassahun H, Cyrille M, Ruzza A, Yoshida M, Kiyosue A, Ma Y, Teramoto T. Hirayama A, et al. Among authors: cyrille m. Circ J. 2017 Jun 23;81(7):1029-1035. doi: 10.1253/circj.CJ-16-1016. Epub 2017 Mar 29. Circ J. 2017. PMID: 28367845 Free article. Clinical Trial.

6

Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period.

Boccara F, Caramelli B, Calmy A, Kumar P, López JAG, Bray S, Cyrille M, Rosenson RS; investigators of the BEIJERINCK study. Boccara F, et al. Among authors: cyrille m. AIDS. 2022 Apr 1;36(5):675-682. doi: 10.1097/QAD.0000000000003175. AIDS. 2022. PMID: 35025817 Clinical Trial.

7

Long-Term Treatment With Evolocumab Among Japanese Patients　- Final Report of the OSLER Open-Label Extension Studies.

Hirayama A, Yamashita S, Ruzza A, Inomata H, Cyrille M, Lu C, Hamer AW, Yoshida M, Kiyosue A, Teramoto T. Hirayama A, et al. Among authors: cyrille m. Circ J. 2019 Apr 25;83(5):971-977. doi: 10.1253/circj.CJ-19-0139. Epub 2019 Mar 29. Circ J. 2019. PMID: 30930429 Free article. Clinical Trial.

8

Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus.

Sattar N, Toth PP, Blom DJ, Koren MJ, Soran H, Uhart M, Elliott M, Cyrille M, Somaratne R, Preiss D. Sattar N, et al. Among authors: cyrille m. Am J Cardiol. 2017 Nov 1;120(9):1521-1527. doi: 10.1016/j.amjcard.2017.07.047. Epub 2017 Jul 31. Am J Cardiol. 2017. PMID: 28844508 Free article. Clinical Trial.

9

Development and validation of the Crohn's disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary.

Higgins PDR, Harding G, Leidy NK, DeBusk K, Patrick DL, Viswanathan HN, Fitzgerald K, Donelson SM, Cyrille M, Ortmeier BG, Wilson H, Revicki DA, Globe G. Higgins PDR, et al. Among authors: cyrille m. J Patient Rep Outcomes. 2017;2(1):24. doi: 10.1186/s41687-018-0044-7. Epub 2018 May 9. J Patient Rep Outcomes. 2017. PMID: 29770803 Free PMC article.

10

Structural and Electrical Response of Emerging Memories Exposed to Heavy Ion Radiation.

Vogel T, Zintler A, Kaiser N, Guillaume N, Lefèvre G, Lederer M, Serra AL, Piros E, Kim T, Schreyer P, Winkler R, Nasiou D, Olivo RR, Ali T, Lehninger D, Arzumanov A, Charpin-Nicolle C, Bourgeois G, Grenouillet L, Cyrille MC, Navarro G, Seidel K, Kämpfe T, Petzold S, Trautmann C, Molina-Luna L, Alff L. Vogel T, et al. Among authors: cyrille mc. ACS Nano. 2022 Sep 27;16(9):14463-14478. doi: 10.1021/acsnano.2c04841. Epub 2022 Sep 16. ACS Nano. 2022. PMID: 36113861 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters